UK Gilt 10 Year Yield 1.3937 Spot Gold $1255.25 -2.55 Brent
Crude $42.79 -14.1
$ per £ 1.4235
$ per € 1.1414
€ per £ 1.2472
U.S. stocks fell, erasing gains in late afternoon trading,
as investors braced for what is forecast to be the worst earnings season since
the financial crisis. The Standard & Poor’s 500 Index fell 0.3 percent to
2,041.99 at 4 p.m. in New York, wiping out an advance of as much as 0.8
percent, after the steepest decline last week in two months. Financial shares,
the worst performing group in the S&P 500 in 2016, gained, with JPMorgan
Chase & Co. and Goldman Sachs Group Inc. climbing. Signs of a pick-up in
Chinese industrial demand pushed raw-material producers higher, while
health-care and consumer-staples companies weighed on the index.
PRESS COMMENTARY
Shire, Endo possible targets for Allergan, dealReporter
said, citing unidentified bankers.
Financial Times: Regulators in Brussels were under intense
pressure to block CK Hutchison’s £10.5 billion deal to acquire UK mobile
operator O2 after the UK competition watchdog intervened, arguing that the
proposed deal would harm British consumers.
The Daily Telegraph: Tata moved a step closer to exiting its
heavily loss-making British steel assets as the Indian conglomerate sold its
Scunthorpe site for £1 at the same time as the Government admitted it could
co-invest in a plan to rescue Port Talbot.
COMPANY NEWS
Asos 1H Retail Gross Margin Beats, On Track to Achieve
Outlook. Asos 1H total rev. GBP667m, est. GBP666m. FY continuing operations
will reflect a higher underlying Ebit margin of ~4.5%, before inclusion of
operating losses in relation to discontinuing operations in China.
Galliford Try responds to press comments following closure
of certain Edinburgh schools. Says has contractual responsibility for four of
the 17 schools in question through its acquisition of Miller Construction. Says
work to remedy defects in these 4 schools is near completion, costs are not
material to the co.
LVMH 1Q total sales EU8.62b, est. EU8.73b. 1Q total organic
sales up 3%, est. up 4.1%. Says U.S. market is strong and Europe remains well
oriented except for France which is affected by a fall in tourism; Asian
markets are varied, Japan continues to progress. Says will maintain a strict
control over costs.
Givaudan 1Q Sales in Line With Estimates, Confirms 2020
Targets. Givaudan 1Q sales of CHF1.15b meet estimates, rises 5.8% on
like-for-like basis, according to e- mailed statement. Co. to maintain current
dividend practice.
AbbVie Inc. and Roche Holding AG’s treatment for a type of leukaemia
won U.S approval almost three months ahead of schedule. Source Quilter Cheviot.
No comments:
Post a Comment